186 related articles for article (PubMed ID: 10399995)
1. Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction. Trace Study Group.
Gustafsson I; Torp-Pedersen C; Køber L; Gustafsson F; Hildebrandt P
J Am Coll Cardiol; 1999 Jul; 34(1):83-9. PubMed ID: 10399995
[TBL] [Abstract][Full Text] [Related]
2. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
Køber L; Torp-Pedersen C; Carlsen JE; Bagger H; Eliasen P; Lyngborg K; Videbaek J; Cole DS; Auclert L; Pauly NC
N Engl J Med; 1995 Dec; 333(25):1670-6. PubMed ID: 7477219
[TBL] [Abstract][Full Text] [Related]
3. Effect of angiotensin converting enzyme inhibition after acute myocardial infarction in patients with arterial hypertension. TRACE Study Group, Trandolapril Cardiac Event.
Gustafsson F; Torp-Pedersen C; Køber L; Hildebrandt P
J Hypertens; 1997 Jul; 15(7):793-8. PubMed ID: 9222948
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibition after myocardial infarction: the Trandolapril Cardiac Evaluation Study.
Torp-Pedersen C; Køber L; Carlsen J
Am Heart J; 1996 Jul; 132(1 Pt 2 Su):235-43. PubMed ID: 8677862
[TBL] [Abstract][Full Text] [Related]
5. The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years.
Buch P; Rasmussen S; Abildstrom SZ; Køber L; Carlsen J; Torp-Pedersen C;
Eur Heart J; 2005 Jan; 26(2):145-52. PubMed ID: 15618070
[TBL] [Abstract][Full Text] [Related]
6. [Trandolapril in patients with left ventricular insufficiency after myocardial infarction].
Aliot E
Arch Mal Coeur Vaiss; 1996 Aug; 89 Spec No 3():23-31. PubMed ID: 8949315
[TBL] [Abstract][Full Text] [Related]
7. Influence of a history of arterial hypertension and pretreatment blood pressure on the effect of angiotensin converting enzyme inhibition after acute myocardial infarction. Trandolapril Cardiac Evaluation Study.
Gustafsson F; Køber L; Torp-Pedersen C; Per Hildebrandt
J Hypertens Suppl; 1998 Jan; 16(1):S65-70. PubMed ID: 9534100
[TBL] [Abstract][Full Text] [Related]
8. Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation.
Torp-Pedersen C; Køber L
Lancet; 1999 Jul; 354(9172):9-12. PubMed ID: 10406358
[TBL] [Abstract][Full Text] [Related]
9. Update on the use of trandolapril in the management of cardiovascular disorders.
Diaz A; Ducharme A
Vasc Health Risk Manag; 2008; 4(6):1147-58. PubMed ID: 19337528
[TBL] [Abstract][Full Text] [Related]
10. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction.
Pedersen OD; Bagger H; Kober L; Torp-Pedersen C
Circulation; 1999 Jul; 100(4):376-80. PubMed ID: 10421597
[TBL] [Abstract][Full Text] [Related]
11. [The significance of trandelapril for mortality after AMI in patients with reduced left ventricular function. TRACE Study Group].
Køber L; Torp-Pedersen CT; Carlsen JE; Bagger H; Eliasen P; Lyngborg K; Videbaek J
Ugeskr Laeger; 1997 Mar; 159(11):1616-22. PubMed ID: 9092145
[TBL] [Abstract][Full Text] [Related]
12. [Trandolapril in the prevention of the sequelae of left ventricular systolic dysfunction after acute myocardial infarct].
Buksa M
Med Arh; 2000; 54(2):103-6. PubMed ID: 10934839
[TBL] [Abstract][Full Text] [Related]
13. Early neurohormonal effects of trandolapril in patients with left ventricular dysfunction and a recent acute myocardial infarction: a double-blind, randomized, placebo-controlled multicentre study.
Sigurdsson A; Eriksson SV; Hall C; Kahan T; Swedberg K
Eur J Heart Fail; 2001 Jan; 3(1):69-78. PubMed ID: 11163738
[TBL] [Abstract][Full Text] [Related]
14. Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction.
Pedersen OD; Gram J; Jeunemaitre X; Billaud E; Jespersen J
Coron Artery Dis; 1997 May; 8(5):283-91. PubMed ID: 9285181
[TBL] [Abstract][Full Text] [Related]
15. Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study Group.
Hansen JF; Hagerup L; Sigurd B; Pedersen F; Mellemgaard K; Pedersen-Bjergaard O; Mortensen LS
Am J Cardiol; 1997 Mar; 79(6):738-41. PubMed ID: 9070551
[TBL] [Abstract][Full Text] [Related]
16. The angiotensin converting enzyme inhibitor trandolapril has neutral effect on exercise tolerance or functional class in patients with myocardial infarction and reduced left ventricular systolic function.
Abdulla J; Burchardt H; Z Abildstrøm S; Køber L; Torp-Pedersen C;
Eur Heart J; 2003 Dec; 24(23):2116-22. PubMed ID: 14643272
[TBL] [Abstract][Full Text] [Related]
17. Trandolapril in left ventricular dysfunction after myocardial infarction: focus on the TRACE study.
Coca A; Rabasseda X
Drugs Today (Barc); 2003 Jan; 39(1):5-18. PubMed ID: 12669106
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and mortality of patients screened for entry into the Trandolapril Cardiac Evaluation (TRACE) study.
Køber L; Torp-Pedersen C
Am J Cardiol; 1995 Jul; 76(1):1-5. PubMed ID: 7793393
[TBL] [Abstract][Full Text] [Related]
19. Trandolapril. An update of its pharmacology and therapeutic use in cardiovascular disorders.
Peters DC; Noble S; Plosker GL
Drugs; 1998 Nov; 56(5):871-93. PubMed ID: 9829159
[TBL] [Abstract][Full Text] [Related]
20. Trandolapril: a newer angiotensin-converting enzyme inhibitor.
Guay DR
Clin Ther; 2003 Mar; 25(3):713-75. PubMed ID: 12852701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]